Zdrowie i gospodarka · 14/06/2018
FDA Announces Draft Guidance for Pre-Exposure HIV-1 Prophylaxis
The FDA has released a draft guidance for industry on developing systemic drug products to prevent HIV-1 infection, focusing on long-acting treatments within the CDER